CIK 0001337013 · Accelerated filer<br>Smaller reporting company
InfuSystem Holdings, Inc
Sign in to watch- Ticker
- INFU
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203341405
- Phone
- (248) 291-1210
- Business address
- 3851 WEST HAMLIN ROAD, ROCHESTER HILLS, MI, 48309
- Former names
- HAPC, Inc., Healthcare Acquisition Partners Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-17 | Sheehan Jeannine Chief Administrative Officer | Grant or award · Restricted Stock Units | +12,955 | 12,955 | ||
| 2022-05-17 | Lachance Carrie President and COO | Grant or award · Stock Option (right to buy) | +25,993 | 25,993 | ||
| 2022-05-17 | Lachance Carrie President and COO | Grant or award · Restricted Stock Units | +17,727 | 17,727 | ||
| 2022-05-17 | Dilorio Richard Chief Executive Officer | Grant or award · Stock Option (right to buy) | +59,984 | 59,984 | ||
| 2022-05-17 | Dilorio Richard Chief Executive Officer | Grant or award · Restricted Stock Units | +40,909 | 40,909 | ||
| 2022-05-17 | Lehman Gregg Owen Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-05-17 | GENDRON PAUL ANDREW Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-05-17 | Sansone Christopher R. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-05-17 | BOYD RALPH F JR Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-05-17 | Shuda Scott Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2022-03-17 | Lehman Gregg Owen Director | Option exercise | +20,000 | $1.98 | $40K | 20,346 |
| 2022-03-17 | Lehman Gregg Owen Director | Sale | −20,000 | $10.75 | $215K | 346 |
| 2022-03-17 | Lehman Gregg Owen Director | Option exercise · Stock Option (right to buy) | −20,000 | $1.98 | $40K | 40,000 |
| 2022-02-18 | Whitman Kevin VP and Corporate Controller | Grant or award · Stock Option (right to buy) | +750 | 750 | ||
| 2022-02-18 | Whitman Kevin VP and Corporate Controller | Grant or award · Restricted Stock Units | +2,250 | 2,250 | ||
| 2022-02-17 | Sansone Christopher R. Director | Option exercise | +25,000 | $1.98 | $50K | 25,000 |
| 2022-02-17 | Sansone Christopher R. Director | Option exercise · Stock Option (right to buy) | −25,000 | 0 | ||
| 2022-02-11 | GENDRON PAUL ANDREW Director | Purchase | +10,000 | $10.67 | $107K | 60,000 |
| 2022-01-24 | Whitman Kevin VP and Corporate Controller | Grant or award · Restricted Stock Units | +2,648 | 2,648 | ||
| 2022-01-24 | Dilorio Richard President & CEO | Option exercise | +33,519 | $2.00 | $67K | 273,354 |
Page 16 of 26 · 507 trades